Device Trial Radar · NCT05559697
Study Comparing iNPWT Dressing and Devices Affect on Bioburden Levels and Skin Condition After Seven Days
Last checked: Nov 20, 2026Latest source record: Mar 12, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
16
Actual
Start
Feb 26, 2024
Primary completion
Mar 7, 2024
Study completion Mar 7, 2024
Sponsor
- Lead sponsor
- DeRoyal Industries, Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Lincoln Memorial University
- First posted
- Sep 29, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 40 years, up to 80 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Incisional dressings aim to prevent contamination of an incisional wound and protect against skin irritation. Surgeons use incisional negative pressure wound therapy (iNPWT) to manage incisional wounds. This study compares a new dressing designed for use with iNPWT that aims to improve comfort, tolerability, and dressing survivability over the standard of care for iNPWT. Further, no evidence exists that shows NPWT reduces the bacterial burden on the skin. This study will compare the incidence of skin irritation, dressing damage or lift, and changes in bacteria flora on healthy volunteer skin.
Conditions
- Skin Reaction to Mechanical, Thermal and Radiation Stimuli
- Skin Sensitisation
Interventions
Sponsor incisional negative pressure wound therapy device and dressingDevice
A sponsor incisional dressing placed on the knee and connected to a sponsor disposable negative pressure therapy device
Standard of Care incisional negative pressure wound therapy systemDevice
The control incisional negative pressure wound therapy system represents the standard of care system and market leader. It consists of a disposable negative pressure therapy device and incisional dressing.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Skin Irritation ScoreTime frame: Day 1 (Baseline) and Day 7
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Lincoln Memorial University; Cedar Bluff Campus
Knoxville, Tennessee
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.